Pharmaceuticals highlight a drug for treating Alzheimer's that is in phase 3 and with its tests indicate that it would reduce cognitive decline by 27%, in the video we tell you that the pharmaceutical companies Biogen and Eisai are looking for with the study.
Advances in Alzheimer's Drug Slows Progression of Cognitive Decline
2022-09-28T15:41:47.736Z
Pharmaceutical companies highlight a drug for treating Alzheimer's that is in phase 3 and with their tests they indicate that it would reduce cognitive decline | CNN